Diabetes Increases Mortality Risk After Acute Myocardial Infarction

This article originally appeared here.
Share this content:
Diabetes Increases Mortality Risk After Acute Myocardial Infarction
Diabetes Increases Mortality Risk After Acute Myocardial Infarction

FRIDAY, June 24, 2016 (HealthDay News) -- Patients with diabetes are much more likely to die after an acute myocardial infarction (AMI) than patients without diabetes, according to a study published online June 15 in the Journal of Epidemiology and Community Health.

Researchers included 703,920 patients in the study, all of whom were hospitalized with AMI between January 2003 and June 2013. In total, 120,568 patients had diabetes.

Compared to patients who didn't have diabetes, those with the disease were 56 percent more likely to die if they had an AMI caused by a completely blocked coronary artery. If their AMI was the result of a partially blocked coronary artery, patients with diabetes were 39 percent more likely to die.

"These results provide robust evidence that diabetes is a significant long-term population burden among patients who have had a heart attack," lead researcher Chris Gale, M.B., B.S., Ph.D., a consultant cardiologist and associate professor in the School of Medicine at the University of Leeds in the United Kingdom, said in a university news release. "Although these days people are more likely than ever to survive a heart attack, we need to place greater focus on the long-term effects of diabetes in heart attack survivors."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »